Locus (ANRIL) was upregulated on mRNA stage in AML individuals of different levels in comparison to standard controls and clients in full remission (CR). Knockdown of ANRIL triggered enhanced senescence in HL-60 and MOLM-13 cells in vitro, and also to elevated survival premiums upon transplantation with the latter in NOD/SCID https://michaell888xjs2.atualblog.com/profile